# Bioanalytical Method Validation for Biomarkers - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/bioanalytical-method-validation-for-biomarkers/dc48cea7-abd8-44db-a6fc-14b002aa59d7

> FDA guidance document: Bioanalytical Method Validation for Biomarkers. Issue date: April 10, 2026. Get complete insights and analysis.

---

## Details

- Title: Bioanalytical Method Validation for Biomarkers
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2026-04-10
- Comment Close Date: 2026-02-28
- Last Changed: 2026-04-10
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2017-D-6821">FDA-2017-D-6821</a>

## Related Documents

- [E6(R3) Good Clinical Practice (GCP)](https://www.globalkeysolutions.net/guidances/guidance-document/e6r3-good-clinical-practice-gcp/682dfcf6-82b9-407c-9ffb-89c51a0a4944)
- [Classification Categories for Certain Supplements Under BsUFA III](https://www.globalkeysolutions.net/guidances/guidance-document/classification-categories-for-certain-supplements-under-bsufa-iii/66d51a68-e6a8-4e86-8097-7ddf219d36b9)
- [E6(R3) GOOD CLINICAL PRACTICE (GCP)](https://www.globalkeysolutions.net/guidances/guidance-document/e6r3-good-clinical-practice-gcp/bfd17ec4-cf4e-4b68-a61c-d3ae1f8a9cd1)